financetom
Business
financetom
/
Business
/
Nextracker Fiscal Q3 Adjusted EPS Rises, Revenue Falls; 2025 Guidance Updated -- Shares Up After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nextracker Fiscal Q3 Adjusted EPS Rises, Revenue Falls; 2025 Guidance Updated -- Shares Up After Hours
Jan 28, 2025 1:45 PM

04:29 PM EST, 01/28/2025 (MT Newswires) -- Nextracker ( NXT ) reported fiscal Q3 adjusted earnings late Tuesday of $1.03 per diluted share, up from $0.96 a year earlier.

Analysts polled by FactSet expected $0.58.

Revenue for the quarter ended Dec. 31 was $679.4 million, compared with $710.4 million a year earlier. Analysts surveyed by FactSet expected $646 million.

For fiscal 2025, the company said it now expects adjusted diluted EPS of $3.75 to $3.95, up from its previous guidance of $3.10 to $3.30. Analysts polled by FactSet expect $3.27.

The company reaffirmed its fiscal 2025 revenue guidance of $2.8 billion to $2.9 billion. Analysts are looking for $2.85 billion.

Nextracker ( NXT ) shares were up 13% in extended trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nissan upbeat on annual profit despite challenges
Nissan upbeat on annual profit despite challenges
May 9, 2024
* Sees FY operating profit of 600 bln yen vs forecast 577 bln * Sees 7.5% rise in global retail sales, China up just 0.8% * Q4 operating profit 90.3 mln yen vs forecast 118.2 bln (Adds vehicle sales forecasts, background on Chinese business throughout) By Daniel Leussink TOKYO, May 9 (Reuters) - Japan's Nissan Motor ( NSANF ) expects...
Enerplus Q1 Earnings, Revenue Decline
Enerplus Q1 Earnings, Revenue Decline
May 9, 2024
04:43 AM EDT, 05/09/2024 (MT Newswires) -- Enerplus ( ERF ) reported Q1 earnings late Wednesday of $0.32 per diluted share, down from $0.62 a year earlier. One analyst polled by Capital IQ expected $0.36. Revenue for the quarter ended March 31 was $359.3 million, down from $441.1 million a year earlier. Comparable analyst estimates for revenue weren't available. Price:...
Takeda Pharmaceutical's Fiscal Q1 Core Earnings Decline, Revenue Increases; Fiscal 2024 Outlook Issued
Takeda Pharmaceutical's Fiscal Q1 Core Earnings Decline, Revenue Increases; Fiscal 2024 Outlook Issued
May 9, 2024
04:24 AM EDT, 05/09/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) reported fiscal Q4 core earnings Thursday of 72 yen ($0.46) per basic share, down from 102 yen a year earlier. Analysts' estimates were not readily available for comparison. Revenue for the quarter ended March 31 was 1.051 trillion yen, up from 956.2 billion yen a year earlier. Analysts...
argenx Q1 Loss Widens, Total Operating Income Rises
argenx Q1 Loss Widens, Total Operating Income Rises
May 9, 2024
04:31 AM EDT, 05/09/2024 (MT Newswires) -- argenx SE (ARGX) reported a Q1 loss Thursday of $1.04 per share, wider than the loss of $0.52 per share a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.70 per share. Total operating income for the quarter ended March 31 was $412.5 million, up from $229.9 million a year...
Copyright 2023-2025 - www.financetom.com All Rights Reserved